The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Persister Cells
Abstract
Persisters are dormant variants of regular cells that form stochastically in microbial populations and are highly tolerant to antibiotics. High persister (hip) mutants of Pseudomonas aeruginosa are selected in patients with cystic fibrosis. Similarly, hip mutants of Candida albicans are selected in patients with an oral thrush biofilm. These observations suggest that persisters may be the main culprit responsible for the recalcitrance of chronic infectious disease to antimicrobial therapy. Screening knockout libraries has not produced mutants lacking persisters, indicating that dormancy mechanisms are redundant. Toxin/antitoxin (TA) modules are involved in persister formation in Escherichia coli. The SOS response leads to overexpression of the TisB toxin and persister formation. TisB is a membrane-acting peptide that apparently sends cells into dormancy by decreasing the proton motive force and ATP levels. Stress responses may act as general activators of persister formation. Proteins required for maintaining persisters may represent realistic targets for discovery of drugs capable of effectively treating chronic infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Persistence is always linked to cell dormancy, a state in which the cellular metabolism temporarily ceases [111,123,124].”
From Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance (2025) · cites this paper as [111]
In the citing paper
“Fungal persisters are dormant variants of wild-type cells that are tolerant to antifungal drugs, surviving high dosage of antifungals that exceed the minimal inhibitory concentration (MIC) [12,16].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [16]
In the citing paper
“It is difficult to detect persisters in planktonic cells, which is different from bacteria [12,16].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [16]
In the citing paper
“This is distinctly different from antibiotic persistence, which is mostly detected in planktonic cells [78].”
From Antifungal persistence: Clinical relevance and mechanisms (2025) · cites this paper as [78]
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collection
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., & Mori, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100050 · Cited by 7,858
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & Costerton, J. W. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,596
Antibacterial resistance worldwide: causes, challenges and responses
Levy, S. B., & Marshall, B. M. (2004) · Nature Medicine · doi:10.1038/nm1145 · Cited by 4,152
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952
Stochasticity in gene expression: from theories to phenotypes
Kærn, M., Elston, T. C., Blake, W. J., & Collins, J. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1615 · Cited by 2,318
Chemotaxis in Escherichia coli analysed by Three-dimensional Tracking
Berg, H. C., & Brown, D. A. (1972) · Nature · doi:10.1038/239500a0 · Cited by 2,239
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052
Self-citation
Research works printed but not linked: 1
- Baltz RA., 2005, SIM News, 55, 188
Cited by
Sorted by citations
Items 101–200 of 1,005
Biofilm formation to inhibition: Role of zinc oxide-based nanoparticles
Mahamuni-Badiger, P. P., Patil, P. M., Badiger, M. V., Patel, P. R., Gadgil, B. S. T., Pandit, A. S., & Bohara, R. A. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110319 · Cited by 277
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271
den Bergh, B. V., Michiels, J. E., Wenseleers, T., Windels, E. M., Boer, P. V., Kestemont, D., Meester, L. D., Verstrepen, K. J., Verstraeten, N., Fauvart, M., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.20 · Cited by 271
Infection microenvironment-related antibacterial nanotherapeutic strategies
Wang, Z., Liu, X., Duan, Y., & Huang, Y. P. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121249 · Cited by 271
Candida glabrata: A review of its features and resistance
Rodrigues, C. F., Silva, S., & Henriques, M. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2009-3 · Cited by 268
Strategy to combat biofilms: a focus on biofilm dispersal enzymes
Wang, S., Zhao, Y., Breslawec, A. P., Liang, T., Deng, Z., Kuperman, L. L., & Yu, Q. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00427-y · Cited by 265
Multiple Toxin-Antitoxin Systems in Mycobacterium tuberculosis
Sala, A. J., Bordes, P., & Genevaux, P. (2014) · Toxins · doi:10.3390/toxins6031002 · Cited by 264
A problem of persistence: still more questions than answers?
Balaban, N. Q., Gerdes, K., Lewis, K., & McKinney, J. D. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3076 · Cited by 263
Self-citationThe Role of Bacterial Biofilms in Device-Associated Infection
Deva, A. K., Adams, W. P., & Vickery, K. (2013) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3182a3c105 · Cited by 263
HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase
Kaspy, I., Rotem, E., Mosheiff, N., Ronin, I., Balaban, N. Q., & Glaser, G. (2013) · Nature Communications · doi:10.1038/ncomms4001 · Cited by 263
Warnes, S. L., Caves, V., & Keevil, C. W. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02677.x · Cited by 261
Bernier, S. P., Lebeaux, D., DeFrancesco, A. S., Valomon, A., Soubigou, G., Coppée, J., Ghigo, J., & Beloin, C. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003144 · Cited by 283
The role of metabolism in bacterial persistence
Amato, S. M., Fazen, C. H., Henry, T. C., Mok, W. W. K., Orman, M. A., Sandvik, E. L., Volzing, K., & Brynildsen, M. P. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00070 · Cited by 269
Dormancy Is Not Necessary or Sufficient for Bacterial Persistence
Orman, M. A., & Brynildsen, M. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00243-13 · Cited by 254
Büttner, H., Mack, D., & Rohde, H. (2015) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2015.00014 · Cited by 261
Abdelrahman, F. I., Easwaran, M., Daramola, O. I., Ragab, S., Lynch, S. A., Oduselu, T. J., Khan, F. M., Ayobami, A., Adnan, F., Torrents, E., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10020124 · Cited by 250
Liu, J., Yang, L., Kjellerup, B. V., & Xu, Z. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.04.009 · Cited by 247
Options and Limitations in Clinical Investigation of Bacterial Biofilms
Magana, M., Sereti, C., Ioannidis, A., Mitchell, C. A., Ball, A. R., Magiorkinis, E., Chatzipanagiotou, S., Hamblin, M. R., Hadjifrangiskou, M., & Tegos, G. P. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-16 · Cited by 259
Phenotypic bistability in Escherichia coli's central carbon metabolism
Kotte, O., Volkmer, B., Radzikowski, J. L., & Heinemann, M. (2014) · Molecular Systems Biology · doi:10.15252/msb.20135022 · Cited by 242
Hoefs, S., Mogavero, S., & Hube, B. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-5514-0 · Cited by 251
Fungal Biofilms and Polymicrobial Diseases
Costa-Orlandi, C. B., Sardi, J. D. C. O., Pitangui, N. D. S., de Oliveira, H. C., Scorzoni, L., Galeane, M. C., Medina‐Alarcón, K. P., Melo, W., Marcelino, M., Braz, J. D., et al. (2017) · Journal of Fungi · doi:10.3390/jof3020022 · Cited by 247
Baharoglu, Z., & Mazel, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01549-10 · Cited by 234
Abebe, A. A., & Birhanu, A. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s428103 · Cited by 242
Stress responses as determinants of antimicrobial resistance in Gram-negative bacteria
Poole, K. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.02.004 · Cited by 237
Persisters, persistent infections and the Yin–Yang model
Zhang, Y. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.3 · Cited by 234
HipBA–promoter structures reveal the basis of heritable multidrug tolerance
Schumacher, M. A., Balani, P., Min, J., Chinnam, N. B., Hansen, S., Vulić, M., Lewis, K., & Brennan, R. G. (2015) · Nature · doi:10.1038/nature14662 · Cited by 243
Self-citationProphages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells
Harms, A., Fino, C., Sørensen, M. A., Semsey, S., & Gerdes, K. (2017) · mBio · doi:10.1128/mbio.01964-17 · Cited by 229
Dewachter, L., Fauvart, M., & Michiels, J. J. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.028 · Cited by 236
Rybtke, M., Hultqvist, L. D., Givskov, M., & Tolker‐Nielsen, T. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.08.016 · Cited by 227
Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells
Conlon, B. P. (2014) · BioEssays · doi:10.1002/bies.201400080 · Cited by 224
Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics
Defraine, V., Fauvart, M., & Michiels, J. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.002 · Cited by 222
Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria
Arzanlou, M., Chai, W. C., & Venter, H. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160063 · Cited by 222
Bacterial persisters: formation, eradication, and experimental systems
Hélaine, S., & Kugelberg, E. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.03.008 · Cited by 221
Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy
Bockenstedt, L. K., Gonzalez, D. G., Haberman, A. M., & Belperron, A. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58813 · Cited by 219
Importance of Biofilms in Urinary Tract Infections: New Therapeutic Approaches
Soto, S. M. (2014) · Advances in Biology · doi:10.1155/2014/543974 · Cited by 219
Effective Removal of Staphylococcal Biofilms by the Endolysin LysH5
Gutiérrez, D., Ruas‐Madiedo, P., Martı́nez, B., Rodrı́guez, A., & García, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107307 · Cited by 218
Emergence of antibiotic resistance from multinucleated bacterial filaments
Bos, J., Zhang, Q., Vyawahare, S., Rogers, E. J., Rosenberg, S. M., & Austin, R. H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420702111 · Cited by 223
Glasser, N. R., Kern, S. E., & Newman, D. K. (2014) · Molecular Microbiology · doi:10.1111/mmi.12566 · Cited by 215
Fighting biofilms with lantibiotics and other groups of bacteriocins
Mathur, H., Field, D., Rea, M. C., Cotter, P. D., Hill, C., & Ross, R. P. (2018) · npj Biofilms and Microbiomes · doi:10.1038/s41522-018-0053-6 · Cited by 223
Martinez, M. N., Papich, M. G., & Drusano, G. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05360-11 · Cited by 212
Diagnosis for Latent Tuberculosis Infection: New Alternatives
Carranza, C., Pedraza‐Sánchez, S., de Oyarzabal-Mendez, E., & Torres, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02006 · Cited by 223
Goormaghtigh, F., Fraikin, N., Putrinš, M., Hallaert, T., Hauryliuk, V., García-Pino, A., Sjödin, A., Kasvandik, S., Udekwu, K. I., Tenson, T., et al. (2018) · mBio · doi:10.1128/mbio.00640-18 · Cited by 210
Toxin-Antitoxin systems: their role in persistence, biofilm formation, and pathogenicity
Wen, Y., Behiels, E., & Devreese, B. V. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12145 · Cited by 209
Review on bacterial biofilm: An universal cause of contamination
Satpathy, S., Sen, S. K., Pattnaik, S., & Raut, S. (2016) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2016.05.002 · Cited by 209
Baquero, F., Coque, T. M., & de la Cruz, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00013-11 · Cited by 212
Epigenetics in natural animal populations
Hu, J., & Barrett, R. D. H. (2017) · Journal of Evolutionary Biology · doi:10.1111/jeb.13130 · Cited by 214
Kim, W., Zou, G., Hari, T. P. A., Wilt, I. K., Zhu, W., Galle, N., Faizi, H. A., Hendricks, G. L., Tori, K., Pan, W., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904700116 · Cited by 208
Fox, E. P., Cowley, E. S., Nobile, C. J., Hartooni, N., Newman, D. K., & Johnson, A. D. (2014) · Current Biology · doi:10.1016/j.cub.2014.08.057 · Cited by 207
Slow growth determines nonheritable antibiotic resistance in Salmonella enterica
Pontes, M. H., & Groisman, E. A. (2019) · Science Signaling · doi:10.1126/scisignal.aax3938 · Cited by 216
Toxin-antitoxin systems are ubiquitous and versatile modulators of prokaryotic cell fate
Schuster, C. F., & Bertram, R. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12074 · Cited by 206
Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection
de Melo, W. C., Avci, P., Moritz, M. N. D. O., Gupta, A. K., Vecchio, D., Sadasivam, M., Chandran, R., Huang, Y., Yin, R., Perussi, L. R., et al. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.811861 · Cited by 211
Barrett, T. C., Mok, W. W. K., Murawski, A. M., & Brynildsen, M. P. (2019) · Nature Communications · doi:10.1038/s41467-019-09058-4 · Cited by 206
Phenotypic Resistance to Antibiotics
Corona, F., & Martinez, J. (2013) · Antibiotics · doi:10.3390/antibiotics2020237 · Cited by 205
Hicks, N. D., Yang, J., Zhang, X., Zhao, B. T., Grad, Y. H., Liu, L., Ou, X., Chang, Z., Xia, H., Zhou, Y., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0218-3 · Cited by 207
A method for high throughput determination of viable bacteria cell counts in 96-well plates
Hazan, R., Que, Y., Maura, D., & Rahme, L. G. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-259 · Cited by 202
Epistasis between antibiotic tolerance, persistence, and resistance mutations
Levin-Reisman, I., Brauner, A., Ronin, I., & Balaban, N. Q. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906169116 · Cited by 216
Teixobactin kills bacteria by a two-pronged attack on the cell envelope
Shukla, R., Lavore, F., Maity, S., Derks, M. G. N., Jones, C. R., Vermeulen, B. J. A., Melcrová, A., Morris, M. A., Becker, L. M., Wang, X., et al. (2022) · Nature · doi:10.1038/s41586-022-05019-y · Cited by 201
Self-citationBriers, Y., Walmagh, M., Grymonprez, B., Biebl, M., Pirnay, J., Defraine, V., Michiels, J. J., Cenens, W., Aertsen, A., Miller, S., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02668-14 · Cited by 201
Mucosal biofilms of Candida albicans
Ganguly, S., & Mitchell, A. P. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.06.001 · Cited by 200
Embers, M. E., Barthold, S. W., Borda, J. T., Bowers, L. C., Doyle, L. A., Hodzic, E., Jacobs, M. B., Hasenkampf, N. R., Martin, D. S., Narasimhan, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029914 · Cited by 197
The Toxin-Antitoxin System DarTG Catalyzes Reversible ADP-Ribosylation of DNA
Jankevicius, G., Ariza, A., Ahel, M., & Ahel, I. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.11.014 · Cited by 204
Cold Plasmas for Biofilm Control: Opportunities and Challenges
Gilmore, B., Flynn, P. B., O’Brien, S., Hickok, N. J., Freeman, T. A., & Bourke, P. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.03.007 · Cited by 195
Tavares, M., Kozak, M., Balola, A., & Sá‐Correia, I. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00139-19 · Cited by 207
Bacteria That Make a Meal of Sulfonamide Antibiotics: Blind Spots and Emerging Opportunities
Deng, Y., Li, B. J., & Zhang, T. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.7b06026 · Cited by 196
The Interaction of Bacteria with Engineered Nanostructured Polymeric Materials: A Review
Armentano, I., Arciola, C. R., Fortunati, E., Ferrari, D., Mattioli, S., Amoroso, C. F., Rizzo, J., Kenny, J. M., Imbriani, M., & Visai, L. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/410423 · Cited by 189
Mycobacterial mistranslation is necessary and sufficient for rifampicin phenotypic resistance
Javid, B., Sorrentino, F., Toosky, M., Zheng, W., Pinkham, J. T., Jain, N. K., Pan, M., Deighan, P., & Rubin, E. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317580111 · Cited by 194
Polke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 205
Pharmacodynamics, Population Dynamics, and the Evolution of Persistence in Staphylococcus aureus
Johnson, P. J., & Levin, B. R. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003123 · Cited by 187
Luidalepp, H., Jõers, A., Kaldalu, N., & Tenson, T. (2011) · Journal of Bacteriology · doi:10.1128/jb.00085-11 · Cited by 187
Bacterial persistence is an active σS stress response to metabolic flux limitation
Radzikowski, J. L., Vedelaar, S. R., Siegel, D. J., Ortega, A. D., Schmidt, A., & Heinemann, M. (2016) · Molecular Systems Biology · doi:10.15252/msb.20166998 · Cited by 186
General Mechanisms Leading to Persister Formation and Awakening
Wilmaerts, D., Windels, E. M., Verstraeten, N., & Michiels, J. J. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.03.007 · Cited by 186
Heterogeneous bacterial persisters and engineering approaches to eliminate them
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.09.002 · Cited by 185
Anti-biofilm agents: recent breakthrough against multi-drug resistantStaphylococcus aureus
Chung, P. Y., & Toh, Y. S. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12141 · Cited by 186
Challenges of antibiotic resistance biofilms and potential combating strategies: a review
Khan, J., Tarar, S. M., Gul, I., Nawaz, U., & Arshad, M. (2021) · 3 Biotech · doi:10.1007/s13205-021-02707-w · Cited by 183
Mannitol Enhances Antibiotic Sensitivity of Persister Bacteria in Pseudomonas aeruginosa Biofilms
Barraud, N., Buson, A., Jarolimek, W., & Rice, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084220 · Cited by 182
Mesoporous Silica‐Based Materials with Bactericidal Properties
Bernardos, A., Piacenza, E., Sancenón, F., Hamidi, M., Maleki, A., Turner, R. J., & Martínez‐Máñez, R. (2019) · Small · doi:10.1002/smll.201900669 · Cited by 181
Pseudomonas aeruginosa biofilms and their partners in crime
Cendra, M. D. M., & Torrents, E. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107734 · Cited by 190
Drug-tolerant persister cells in cancer: the cutting edges and future directions
Pu, Y., Li, L., Peng, H., Liu, L., Heymann, D., Robert, C., Vallette, F. M., & Shen, S. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00815-5 · Cited by 189
Cywes‐Bentley, C., Skurnik, D., Zaidi, T., Roux, D., DeOliveira, R. B., Garrett, W. S., Lü, X., O'Malley, J. M., Kinzel, K., Zaidi, T. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303573110 · Cited by 178
Candida auris: Disinfectants and Implications for Infection Control
Ku, T. S. N., Walraven, C. J., & Lee, S. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00726 · Cited by 177
Microbial biofilm formation: a need to act
Römling, U., Kjelleberg, S. J., Normark, S. J., Nyman, L., Uhlin, B. E., & Åkerlund, B. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12242 · Cited by 185
Microbial bet-hedging: the power of being different
Grimbergen, A. J., Siebring, J., Solopova, A., & Kuipers, O. P. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.04.008 · Cited by 177
Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells
Sharma, B., Brown, A. V., Matluck, N. E., Hu, L. T., & Lewis, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00864-15 · Cited by 175
Self-citationBiologically Active and Antimicrobial Peptides from Plants
Salas, C. E., Badillo-Corona, J. A., Ramírez-Sotelo, M.-G., & Oliver-Salvador, C. (2015) · BioMed Research International · doi:10.1155/2015/102129 · Cited by 180
Xiang, H., Cao, F., Di, M., Zheng, Y., Dong, X., Zhong, X., Mu, D., Li, B., Zhong, L., Cao, J., et al. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8403-5 · Cited by 175
Trastoy, R., Manso, T., Fernández-García, L., Blasco, L., Ambroa, A., del Molino, M. L. P., Bou, G., García‐Contreras, R., Wood, T. K., & Tomás, M. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-18 · Cited by 185
Pribis, J. P., Garcı́a-Villada, L., Zhai, Y., Lewin‐Epstein, O., Wang, A. Z., Liu, J., Xia, J., Mei, Q., Fitzgerald, D. M., Bos, J., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.037 · Cited by 177
The role of bacterial metabolism in antimicrobial resistance
Ahmad, M., Aduru, S. V., Smith, R. P., Zhao, Z., & Lopatkin, A. J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01155-0 · Cited by 186
Saunders, E. C., Ng, W. W., Kloehn, J., Chambers, J. M., Ng, M., & McConville, M. J. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003888 · Cited by 171
Toxin–antitoxin systems and their role in disseminating and maintaining antimicrobial resistance
Yang, Q., & Walsh, T. R. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux006 · Cited by 170
Thinking Outside the Box—Novel Antibacterials To Tackle the Resistance Crisis
Lakemeyer, M., Zhao, W., Mandl, F. A. M., Hammann, P., & Sieber, S. A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201804971 · Cited by 173
Converting Cancer Therapies into Cures: Lessons from Infectious Diseases
Glickman, M. S., & Sawyers, C. L. (2012) · Cell · doi:10.1016/j.cell.2012.02.015 · Cited by 171
Antimicrobial Drugs in Fighting against Antimicrobial Resistance
Cheng, G., Dai, M., Ahmed, S., Hao, H., Wang, X., & Yuan, Z. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00470 · Cited by 172
Klotz, A., Georg, J., Bučinská, L., Watanabe, S., Reimann, V., Januszewski, W., Sobotka, R., Jendrossek, D., Hess, W. R., & Forchhammer, K. (2016) · Current Biology · doi:10.1016/j.cub.2016.08.054 · Cited by 169
Biofilm Formation in Food Processing Environments is Still Poorly Understood and Controlled
Cappitelli, F., Polo, A., & Villa, F. (2014) · Food Engineering Reviews · doi:10.1007/s12393-014-9077-8 · Cited by 168
Molecular mechanisms and clinical implications of bacterial persistence
Michiels, J. E., den Bergh, B. V., Verstraeten, N., & Michiels, J. J. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.10.002 · Cited by 173
The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis
Vilchèze, C., & Jacobs, W. R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.016 · Cited by 164
Scaffold-based Anti-infection Strategies in Bone Repair
Johnson, C. T., & Garcı́a, A. J. (2014) · Annals of Biomedical Engineering · doi:10.1007/s10439-014-1205-3 · Cited by 163
Bacterial persistence increases as environmental fitness decreases
Hong, S. H., Wang, X., O’Connor, H. F., Benedik, M. J., & Wood, T. K. (2012) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2011.00327.x · Cited by 162
Leung, V., & Levesque, C. M. (2012) · Journal of Bacteriology · doi:10.1128/jb.06707-11 · Cited by 162
Metadata
- Authors
- Lewis, K.
- Affiliations
- Northeastern University (US)
- Corresponding author
- Lewis, Kim
- ORCID
- Lewis, Kim
- Venue
- Annual Review of Microbiology
- Publisher
- Annual Reviews
- Published
- 2010-10-13
- Volume
- 64
- Issue
- 1
- Pages
- 357-372
- ISSN
- 0066-4227 (ISSN-L)
- 1545-3251
- OpenAlex
- W4213353716
- Cited by
- 1,858
- References
- 92
- Citations by year
- 2026: 96 · 2025: 95 · 2024: 110 · 2023: 106 · 2022: 134 · 2021: 146 · 2020: 131 · 2019: 162 · 2018: 124 · 2017: 121 · 2016: 143 · 2015: 132 · 2014: 122 · 2013: 98 · 2012: 81
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM061162)
- National Institute of Allergy and Infectious Diseases (T-R01AO085585)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- persister cells, antibiotic tolerance, dormancy, Pseudomonas aeruginosa, Candida albicans, cystic fibrosis, toxin-antitoxin systems, SOS response, chronic infection, antimicrobial resistance, stress response, proton motive force, therapeutic target
- MeSH terms
- Anti-Bacterial Agents, Antifungal Agents, Candida albicans, Escherichia coli, Humans, Pseudomonas aeruginosa, Drug Resistance, Bacterial, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review